Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization.

Building from the results of a computational screen of a range of triazole-containing compounds for binding efficiency to human immunodeficiency virus type 1 protease (HIV-1-Pr), a novel series of potent inhibitors has been developed. The copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC), which provides ready access to 1,4-disubstituted-1,2,3-triazoles, was used to unite a focused library of azide-containing fragments with a diverse array of functionalized alkyne-containing building blocks. In combination with direct screening of the crude reaction products, this method led to the rapid identification of a lead structure and readily enabled optimization of both azide and alkyne fragments. Replacement of the triazole with a range of alternative linkers led to greatly reduced protease inhibition; however, further functionalization of the triazoles at the 5-position gave a series of compounds with increased activity, exhibiting Ki values as low as 8 nM.

Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-nitroimidazole and antimicrobial activity against Giardia lamblia.

Infections with the diarrheagenic pathogen, Giardia lamblia, are commonly treated with the 5-nitroimidazole (5-NI) metronidazole (Mz), and yet treatment failures and Mz resistance occur. Using a panel of new 2-ethenyl and 2-ethanyl 5-NI derivatives, we found that compounds with a saturated bridge between the 5-NI core and a pendant ring system exhibited only modestly increased antigiardial activity and could not overcome Mz resistance. By contrast, olefins with a conjugated bridge connecting the core and a substituted phenyl or heterocyclic ring showed greatly increased antigiardial activity without toxicity, and several overcame Mz resistance and were more effective than Mz in a murine giardiasis model. Determination of the half-wave potential of the initial one-electron transfer by cyclic voltammetry revealed that easier redox activation correlated with greater antigiardial activity and capacity to overcome Mz resistance. These studies show the potential of combining systematic synthetic approaches with biological and electrochemical evaluations in developing improved 5-NI drugs.

Stereochemistry of hexenyl radical cyclizations with tert-butyl and related large groups: substituent and temperature effects.

The long held notion that hexenyl radicals bearing large substituents on the radical carbon cyclize to give 1,2-trans-substituted cyclopentanes is experimentally disproved by study of the radical cyclization of an assortment of simple and complex substrates coupled with careful product analysis and rigorous assignment of configurations. X-ray studies and syntheses of authentic samples establish that the published assignments for cis- and trans-1-tert-butyl-2-methylcyclopentane must be reversed. The original assignment based on catalytic hydrogenation of 1-tert-butyl-2-methylenecyclopentane was compromised by migration of the double bond prior to hydrogenation. The cyclization of 1-tert-butylhexenyl radical is moderately cis selective, and the selectivity is increased by geminal substitution on carbon 3. This selectivity trend is general and extends to relatively complex substrates. It has allowed Ihara to reduce the complexity of an important class of round trip radical cyclizations to make linear triquinanes to the point where two tricyclic products-cis-syn-cis and cis-anti-cis-account for about 80% of the products. However, the further increase in selectivity that was proposed by lowering the temperature is shown to be an artifact of the analysis methods and is not correct. This work solidifies "1,2-cis selectivity" in cyclizations of 1-subsituted hexenyl radicals as one of the most general stereochemical trends in radical cyclizations.